Steven Cohen Affimed N.V. Transaction History

Point72 Asset Management, L.P.

$36.6 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.46 - $0.65 $7,736 - $10,932	-16,819 Reduced 0.4%	4,225,820 $2.03 Million
Q2 2023 Aug 14, 2023	BUY	$0.57 - $1.08 $9,586 - $18,164	16,819 Added 0.4%	4,242,639 $2.55 Million
Q1 2023 May 15, 2023	BUY	$0.66 - $1.29 $12,276 - $23,994	18,600 Added 0.44%	4,225,820 $3.17 Million
Q4 2022 Feb 14, 2023	SELL	$1.1 - $2.45 $1.3 Million - $2.89 Million	-1,179,300 Reduced 21.89%	4,207,220 $5.22 Million
Q3 2022 Nov 14, 2022	SELL	$1.96 - $3.32 $2.08 Million - $3.53 Million	-1,062,500 Reduced 16.48%	5,386,520 $11.1 Million
Q2 2022 Aug 15, 2022	SELL	$2.27 - $4.86 $6.61 Million - $14.2 Million	-2,913,431 Reduced 31.12%	6,449,020 $17.9 Million
Q1 2022 May 16, 2022	SELL	$3.69 - $5.65 $9.2 Million - $14.1 Million	-2,492,700 Reduced 21.03%	9,362,451 $40.9 Million
Q4 2021 Feb 14, 2022	BUY	$5.37 - $7.07 $30.8 Million - $40.5 Million	5,732,500 Added 93.63%	11,855,151 $65.4 Million
Q3 2021 Nov 15, 2021	BUY	$5.54 - $7.51 $4.36 Million - $5.91 Million	786,748 Added 14.74%	6,122,651 $37.8 Million
Q2 2021 Aug 16, 2021	BUY	$7.78 - $11.4 $390,517 - $572,223	50,195 Added 0.95%	5,335,903 $45.4 Million
Q1 2021 May 17, 2021	BUY	$5.12 - $8.48 $11.3 Million - $18.7 Million	2,210,708 Added 71.89%	5,285,708 $41.8 Million
Q4 2020 Feb 16, 2021	BUY	$3.16 - $7.03 $3.4 Million - $7.56 Million	1,075,000 Added 53.75%	3,075,000 $17.9 Million
Q3 2020 Nov 16, 2020	SELL	$3.26 - $4.73 $4.76 Million - $6.91 Million	-1,461,093 Reduced 42.21%	2,000,000 $6.78 Million
Q2 2020 Aug 14, 2020	BUY	$1.58 - $4.63 $2.78 Million - $8.15 Million	1,761,093 Added 103.59%	3,461,093 $16 Million
Q4 2019 Feb 14, 2020	BUY	$2.25 - $3.07 $2.7 Million - $3.68 Million	1,200,000 Added 240.0%	1,700,000 $4.66 Million
Q3 2019 Nov 15, 2019	BUY	$2.67 - $3.65 $1.34 Million - $1.83 Million	500,000 New	500,000 $1.47 Million
Q3 2018 Nov 14, 2018	SELL	$1.45 - $6.15 $362,500 - $1.54 Million	-250,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$1.25 - $2.65 $312,500 - $662,500	250,000 New	250,000 $463,000
Q4 2017 Feb 14, 2018	SELL	$1.23 - $2.3 $359,936 - $673,051	-292,631 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$1.95 - $2.25 $570,630 - $658,419	292,631	292,631 $658,000

Others Institutions Holding AFMD

# of Institutions

Shares Held

1.09M

Call Options Held

Put Options Held

View Full List

About Affimed N.V.

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $185M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

More about AFMD

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account